Study at a glance
Why can similar vitamin D blood levels have different effects?
This page summarises evidence about why people with similar vitamin D blood levels can respond differently. The usual test measures 25-hydroxyvitamin D, shortened to 25(OH)D. It describes vitamin D status, but it does not directly measure every process that follows inside tissues.
Why can the body’s response to vitamin D differ?
Proteins carry vitamin D through blood, and tissues differ in how they take it up. Cells then control how much becomes active and how quickly it is broken down. They also need working vitamin D receptors, structures that receive chemical signals. Differences in these steps can change the response even when measured blood levels are similar.
What did studies in people find about vitamin D responses?
In one intervention study, healthy adults differed in blood measurements and changes inside cells after vitamin D3 exposure. Researchers used these measurements to describe high, middle and low responses. Related research found changes in how accessible DNA was to the machinery controlling genes. These results concern particular measured responses, rather than one measure of every vitamin D effect.
How much did genetics explain the rise in vitamin D levels?
A separate randomised trial found that common genetic differences affected the rise in 25(OH)D after supplements. The effects did not fully determine a person’s response. Starting vitamin D levels, body composition, environment and whether supplements were taken as planned also mattered. The main conclusion is that blood testing remains useful, while biological responses depend on additional factors.
Read the full article below ↓Similar serum 25-hydroxyvitamin D [25(OH)D] concentrations do not guarantee identical vitamin D biology. The measured value reflects circulating status, but downstream response also depends on binding and transport, local activation by CYP27B1, degradation through CYP24A1, vitamin D receptor signalling, tissue context, genetics and the biological endpoint being measured. These modifiers help explain why two people with comparable blood results can still differ in molecular or physiological response. For the complete evidence treatment, see Why Similar Vitamin D Levels Can Produce Different Biological Responses: Full Study.
The circulating concentration is only one layer
Most 25(OH)D is carried by vitamin D-binding protein, and tissues differ in how metabolites are delivered and taken up. The precursor must then be activated, regulated and interpreted through cellular signalling. That means a similar total serum concentration does not establish identical tissue exposure or identical active-hormone signalling. The distinction is part of Vitamin D Status vs Vitamin D Effect.
Activation, degradation and receptor biology can modify response
CYP27B1 converts 25(OH)D to 1,25-dihydroxyvitamin D, while CYP24A1 participates in inactivation and degradation. Their regulation differs between tissues. Even when active hormone is present, the receiving cell must express a competent vitamin D receptor and the necessary regulatory machinery. Vitamin D Receptor Sensitivity and Density therefore represents one important layer of inter-individual and tissue-specific variation.
Human studies demonstrate personalized response patterns
In the VitDbol intervention study, healthy adults showed substantial variation in vitamin D metabolite, PTH and molecular responses after vitamin D₃ exposure. Participants could be grouped into high, mid and low responders using the study’s response measures. Related epigenomic work showed that vitamin D supplementation can alter chromatin accessibility in vivo. These findings support the broader concept of Vitamin D Response: equal exposure or similar measured status need not produce identical downstream change.
Genetics contributes but does not determine the outcome
A randomized trial found that common variants near CYP2R1, CYP24A1 and VDR modified the increase in serum 25(OH)D after vitamin D₃ supplementation. Variants in GC and CYP2R1 were also associated with baseline concentrations. These effects support a genetic contribution to response variability, but they were not large enough to justify treating genotype as destiny. Environment, body composition, baseline status, adherence and tissue context also matter.
Bottom line
A serum 25(OH)D result remains useful for describing vitamin D status, but it cannot encode every downstream determinant of biological effect. Similar measured levels can coexist with different metabolite handling, receptor signalling and molecular responses. The correct interpretation is therefore layered: measure status with an appropriate biomarker, then recognise that functional outcome depends on physiology beyond the number.
Primary scientific sources and publication details
Seuter S, Virtanen JK, Nurmi T, et al. Molecular evaluation of vitamin D responsiveness of healthy young adults. Journal of Steroid Biochemistry and Molecular Biology. 2017;174:314-321. PMID: 27282116.
Barry EL, Rees JR, Peacock JL, et al. Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial. Journal of Clinical Endocrinology & Metabolism. 2014;99(10):E2133-E2137. PMCID: PMC4184076.
Carlberg C, Seuter S, Nurmi T, et al. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. Journal of Steroid Biochemistry and Molecular Biology. 2018;180:142-148. PMID: 29317287.
Related reading
Evolution of Vitamin D Status and Vitamin D Receptor Gene Expression Among Professional Handball Athletes During a Competitive Period. Relationship with Body Composition, Calcium, Magnesium and Phosphorous
Introduction: A generalized risk of vitamin D deficiency exists worldwide affecting also professional and elite athletes.
Original paper ↗Read more →The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial
The objective of this randomised controlled study is to examine the effect of vitamin D supplementation on body composition and the expression of the vitamin D receptor (VDR) mRNA.
Original paper ↗Read more →Upregulation of Placental Vitamin D Receptor Expression in Gestational Diabetes Is Not Directly Related to Vitamin D Concentration
This study aimed to examine the expression of the vitamin D receptor in the placenta of patients with gestational diabetes mellitus and healthy women.
Original paper ↗Read more →Vitamin D Receptor Structure and Ligand Recognition: Evidence Synthesis
Evidence synthesis of VDR ligand-binding and DNA-binding structure, RXR partnership, response-element recognition and alternative ligand binding.
Read more →Why Similar Vitamin D Levels Can Produce Different Biological Responses: Full Study
A full study of why similar vitamin D levels can produce different biological responses through transport, metabolism, VDR signalling and genetics.
Read more →Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor
We here aimed to identify a potential interaction between bile acids and CD4+ Th cells, which are central in adaptive immune responses.
Original paper ↗Read more →Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25‐Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor‐23
The hormonal vitamin D metabolite, 1,25‐dihydroxyvitamin D [1,25(OH)2D], produced in kidney, acts in numerous end organs via the nuclear vitamin D receptor (VDR) to trigger molecular events that orchestrate bone mineral homeostasis.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Downregulation of serum vitamin D receptor level, serum 25-hydroxyvitamin D, and association of vitamin D receptor gene polymorphisms ApaI and TaqI with obesity in the Bangladeshi population
The purpose of our study was to investigate the association between two single-nucleotide polymorphisms (SNPs) (Apal, rs7975232, and Taql, rs731236) of the VDR gene and the risk of obesity in the Bangladeshi population.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Level and VDR Gene Single Nucleotide Polymorphism rs2228570 Influence on COVID-19 Susceptibility among the Kazakh Ethnic Group: A Pilot Study
We compared the 25(OH)D plasma levels and concluded that the COVID-19-positive group values (25.17 ng/mL ± 16.65) were statistically lower (p = 0.0114) compared to the COVID-19-negative ones (35.58 ng/mL ± 20.67).
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Levels and VDR Gene Expression in Peripheral Blood Mononuclear Cells of Leukemia Patients and Healthy Subjects in Central Kazakhstan
A similar difference was observed in both younger (60 years old) participants, though there was no association between 25(OH)D concentration and age within the patient group.
Original paper ↗Read more →Relationship Between Vitamin D Receptor Gene BsmI Polymorphism and 25-Hydroxyvitamin D Total Levels in Slovak Postmenopausal Women with Reduced Bone Mineral Density
The aim of the study was to investigate the relationship between the VDR gene BsmI polymorphism and 25(OH)D levels in Slovak postmenopausal women.
Original paper ↗Read more →Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population
This study aimed to evaluate the association of four variants in the VDR gene (rs7975232, rs1544410, rs731236, and rs2228570) with T1DM risk and vitamin D levels within a population from North Region, Brazil, as well as the influence of genomic ancestry on T1DM.
Original paper ↗Read more →Vitamin D Genetics Beyond Serum 25(OH)D: VDR rs2228570 (FokI) Polymorphism, Inflammation, and Quality of Life in Orthopedic Patients
This study investigated the rs2228570 (FokI) variant in relation to inflammatory, hematologic, and patient-reported outcomes in orthopedic patients.
Original paper ↗Read more →Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease
We aimed to investigate VDR binding in primary CD4+ cells from healthy volunteers.
Original paper ↗Read more →Vitamin D Receptor Sensitivity and Density
Vitamin D receptor sensitivity and density help explain why vitamin D responses vary between individuals.
Read more →Association between 25-Hydroxyvitamin D and Metabolic Syndrome in Older Adults: The Health, Aging and Body Composition Study
A total of 1620 white and 1016 black participants aged 70 to 79 years from the Health ABC cohort with measured 25(OH)D levels and data on MetS and covariates of interest were examined.
Original paper ↗Read more →Association of 25-hydroxyvitamin D with sex hormones and body composition in Chinese older adults
Anthropometric measurements, biochemical characteristics, sex hormones, body composition, and chronic comorbidities were compared after stratification by 25-(OH)D levels.
Original paper ↗Read more →Body Composition Attenuates the Association Between Serum 25-Hydroxyvitamin D and Bone Mineral Density in Early Postmenopausal Women
Associations were examined using Spearman correlations and multivariable linear and logistic regression models adjusted for age, body weight, lean mass, and years since menopause.
Original paper ↗Read more →Do Serum 25-Hydroxyvitamin D Concentrations Affect Body Composition, Physical Fitness, Bone Strength and Bone Biomarkers in Female Children and Adolescent Football Players? A One-Season Study
The aim was to compare changes in body composition, physical fitness, and bone biomarkers in female children and adolescent football players with different Vitamin D levels.
Original paper ↗Read more →Serum free 25(OH)D concentrations and cardiovascular disease, heart failure, kidney function decline, and fracture: the health, aging, and body composition study
We evaluated the relationship of free vitamin D with incident cardiovascular disease (CVD), heart failure (HF), kidney function decline (KFD) and fracture, among 786 participants in the Health Aging and body composition study.
Original paper ↗Read more →Original sources
Molecular evaluation of vitamin D responsiveness of healthy young adults
Published in Journal of Steroid Biochemistry and Molecular Biology (2017).
Publication details
Seuter S, Virtanen JK, Nurmi T, et al. Molecular evaluation of vitamin D responsiveness of healthy young adults. Journal of Steroid Biochemistry and Molecular Biology. 2017;174:314-321. PMID: 27282116.
Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial
Published in Journal of Clinical Endocrinology & Metabolism (2014).
Publication details
Barry EL, Rees JR, Peacock JL, et al. Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial. Journal of Clinical Endocrinology & Metabolism. 2014;99(10):E2133-E2137. PMCID: PMC4184076.
In vivo response of the human epigenome to vitamin D: A Proof-of-principle study
Published in Journal of Steroid Biochemistry and Molecular Biology (2018).
Publication details
Carlberg C, Seuter S, Nurmi T, et al. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. Journal of Steroid Biochemistry and Molecular Biology. 2018;180:142-148. PMID: 29317287.